![]() |
市場調查報告書
商品編碼
1631118
美國輻照設備市場規模、佔有率、趨勢分析報告:按類型、應用、最終用途和細分市場預測,2025 年至 2030 年U.S. Irradiation Apparatus Market Size, Share & Trends Analysis Report By Type, By Application, End-use, And Segment Forecasts, 2025 - 2030 |
預計 2024 年美國輻照設備市場價值將達到 28.8 億美元,2025 年至 2030 年期間複合年成長率為 6.0%。
對非侵入性醫療程序的需求不斷成長是輻照設備市場成長的主要驅動力。非侵入性手術通常需要精確的消毒和設備,隨著患者和醫療保健提供者尋求傳統侵入性方法的替代方法,非侵入性手術越來越受歡迎。此外,核子醫學診斷和治療應用中輻照設備的使用越來越多,進一步推動了市場的成長。
癌症、心血管疾病、肌肉骨骼疾病、攝護腺癌和乳癌等慢性疾病的發生率不斷上升,是採用非侵入性診斷解決方案的主要促進因素。這些疾病需要先進的影像技術,X光等放射設備被廣泛使用。這些設備能夠實現早期和準確的診斷,從而無需進行侵入性手術即可及時干預和治療。此外,到 2022 年,美國癌症患者數量預計將達到 190 萬人。據美國癌症協會稱,肺癌是最常見的癌症之一,預計僅 2024 年美國出現超過 234,580 例新病例。此外,2022 年美國前列腺癌的發生率和盛行率為 230,125。這一趨勢反映了醫療保健領域向非侵入性方法的更廣泛轉變,這種方法可以改善患者的治療效果並優先考慮患者的安全和療效。
核子醫學範圍的擴大,導致對保證醫學影像診斷和治療高精度的輻照設備的需求日益增加。這一趨勢凸顯了輻照器在提高美國衛生服務能力方面的重要作用。低分次放射治療的使用促進了美國放射設備市場的顯著成長。這種治療方法可以在較少的療程中提供更高劑量的輻射,從而提高患者的依從性和治療效果,同時降低整體醫療成本。這種方法最佳化了現有設備的使用,使現有的放射治療系統更有效率。它也推動了對影像導航放射治療(IGRT) 和強度調控放射治療(IMRT) 等先進技術的需求,這些技術對於提供精準有效的治療至關重要。因此,這些進步和治療創新正在推動美國輻照設備市場的成長。
此外,強度調控放射治療影像導航放射治療治療和立體定位放射治療,正在增強癌症治療。這一趨勢有助於增加對患病腫瘤的放射劑量,同時減少對健康組織的影響。例如,2024 年 6 月,賽默飛世爾科技推出了 NetDose PRO,這是一款輻射劑量計,旨在提高測量輻射暴露劑量的安全性和準確性。此劑量計經過NVLAP(國家自願實驗室認可計畫)認證,符合高安全標準。 NetDose PRO 旨在改善各種環境中的輻射監測,包括醫療和研究。賽默飛世爾科技 NetDose PRO 輻射劑量計的推出彰顯了輻射安全技術的進步,這對於使用輻照器的環境至關重要。
The U.S. irradiation apparatus market size was estimated at USD 2.88 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. The increasing demand for non-invasive medical procedures is a significant driving factor in the growth of the irradiation apparatus market. As patients and healthcare providers seek alternatives to traditional invasive methods, non-invasive procedures, which often require precise sterilization and equipment, are gaining popularity. Furthermore, the increased usage of irradiation devices in nuclear medicine for diagnostic and therapeutic applications further propels market growth.
The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, musculoskeletal disorders, prostate cancer, and breast cancer is a significant driver for the adoption of non-invasive diagnostic solutions. These conditions necessitate sophisticated imaging techniques, where X-ray and other irradiation apparatus are widely used. Such devices enable early and accurate diagnosis, allowing timely intervention and treatment that does not require invasive procedures. Furthermore, the number of cancer cases in the U.S. reached 1.9 million in 2022. According to the American Cancer Society, lung cancer is one of the most diagnosed cancers, with over 234,580 new cases expected in the U.S. in 2024 alone. Furthermore, the incidence and rate of prostate cancer in 2022 in the U.S. were 230,125. This trend enhances patient outcomes and reflects a broader shift within the healthcare sector toward non-invasive approaches that prioritize patient safety and efficacy.
The expanding scope of nuclear medicine has driven the demand for irradiation equipment that ensures high precision in medical imaging and treatment delivery. This trend underscores the critical role of irradiation apparatus in enhancing the capabilities of healthcare services in the U.S. The usage of hypo-fractionated radiotherapy contributes to notable growth in the U.S. market for irradiation apparatus. This treatment method, which delivers higher doses of radiation over fewer sessions, improves patient adherence and treatment outcomes while reducing overall healthcare costs. This approach optimizes the use of current equipment, making existing radiotherapy systems more efficient. Furthermore, it fuels demand for advanced technologies such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT), essential for delivering precise and effective treatment. Consequently, these advancements and treatment innovations drive market growth for irradiation apparatus in the U.S.
Furthermore, technological innovations in radiation therapies, such as intensity-modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiotherapy, have enhanced cancer treatments. The trend helps to increase the radiation dose to affected tumors and, simultaneously, reduce the effects on the healthy tissues. For instance, In June 2024, Thermo Fisher Scientific launched the NetDose PRO radiation dosimeter, designed to enhance safety and accuracy in measuring radiation exposure. This device is accredited by the National Voluntary Laboratory Accreditation Program (NVLAP), ensuring it meets high safety standards. The NetDose PRO aims to improve radiation monitoring in various settings, including healthcare and research environments. The launch of Thermo Fisher Scientific's NetDose PRO radiation dosimeter highlights advancements in radiation safety technology, which is crucial for environments utilizing irradiation devices.
U.S. Irradiation Apparatus Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. irradiation apparatus market report based on type, application, and end-use: